Targeting aryl hydrocarbon receptor signaling attenuates hypertension programmed by maternal Di-2-ethylhexylphthalate exposure
Toxicology and Applied Pharmacology · 2026
DOI: 10.1016/j.taap.2026.117751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicology and Applied Pharmacology, 2026. Verfasst von Chien-Ning Hsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwa…. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Hypertension, Diethylhexyl Phthalate, Prenatal Exposure Delayed Effects. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Adverse early-life conditions can predispose offspring to long-term health risks. Phthalate exposure, particularly to di-2-ethylhexylphthalate (DEHP), during pregnancy and lactation has been implicated in programming offspring hypertension via aryl hydrocarbon receptor (AHR) activation, renin-angiotensin system (RAS) dysregulation, nitric oxide (NO) deficiency, and gut microbiota alterations. Using a maternal DEHP exposure rat model, we investigated whether blockade of AHR signaling-directly with the AHR inhibitor CH223191 or indirectly with the indoleamine 2,3-dioxygenase (IDO) inhibitor INCN-024360-prevents offspring hypertension. Pregnant rats received DEHP (10 mg/kg/day) by oral gavage throughout pregnancy and lactation, with or without CH223191 (10 mg/kg/day) or INCN-024360 (50 mg/kg/day). Maternal DEHP exposure induced sustained systolic hypertension in adult male offspring, accompanied by upregulation of renal AHR signaling and RAS components. This effect was attenuated by the IDO inhibitor (approximately 10 mmHg reduction in systolic blood pressure) and more effectively by the AHR inhibitor (approximately 16 mmHg reduction). Mechanistically, the IDO inhibitor reduced asymmetric dimethylarginine (an endogenous nitric oxide synthase inhibitor), renin, and CYP1A1 expression while increasing angiotensin-converting enzyme 2 (ACE2), whereas the AHR inhibitor suppressed renal AHR, renin, angiotensin-converting enzyme (ACE), and angiotensin II type 1 receptor (AT1R) expression and significantly enhanced short-chain fatty acid receptor expression. Both interventions were associated with distinct alterations in gut microbiota composition. These findings identify AHR as a key mechanistic link between early-life environmental phthalate exposure and programmed hypertension and support early-life AHR blockade as a potential preventive strategy for offspring cardiometabolic-kidney risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohs…
- Division of Critical Care, Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taiwan.
- Department of Seafood Science, National Kaohsiung University of Science and Technology, Kaohsiung, Taiwan.
- Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; Department of Food Science and Biotechnology, National Chung Hsing University, Taichung, Taiwan.
- Center for Environmental Toxin and Emerging-Contaminant Research, Cheng Shiu University, Kaohsiung, Taiwan; Institute of Environmental Toxin and Emerging-Contaminant, Cheng Shiu University, Kaohsiung, Taiwan; Super Micr…
- Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung…
Förderung
- National Science and Technology Council
Zitieren
APA
Hsu, C. N., Liu, H. Y., Hou, C. Y., Chen, Y. W., Chang-Chien, G. P., Lin, S. F., & Tain, Y. L. (2026). Targeting aryl hydrocarbon receptor signaling attenuates hypertension programmed by maternal Di-2-ethylhexylphthalate exposure. Toxicology and Applied Pharmacology. https://doi.org/10.1016/j.taap.2026.117751
Vancouver
Hsu CN, Liu HY, Hou CY, Chen YW, Chang-Chien GP, Lin SF, et al. Targeting aryl hydrocarbon receptor signaling attenuates hypertension programmed by maternal Di-2-ethylhexylphthalate exposure. Toxicology and Applied Pharmacology. 2026. doi:10.1016/j.taap.2026.117751
BibTeX
@article{Hsu2026,
author = {Hsu, Chien-Ning and Liu, Hsi-Yun and Hou, Chih-Yao and Chen, Yu-Wei and Chang-Chien, Guo-Ping and Lin, Shu-Fen and Tain, You-Lin},
title = {Targeting aryl hydrocarbon receptor signaling attenuates hypertension programmed by maternal Di-2-ethylhexylphthalate exposure},
journal = {Toxicology and Applied Pharmacology},
year = {2026},
doi = {10.1016/j.taap.2026.117751}
}
EUVIMED